A Multi-Method Approach for Proteomic Network Inference in 11 Human Cancers.

PLoS Comput Biol 2016 Feb 29;12(2):e1004765. Epub 2016 Feb 29.

Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.

Protein expression and post-translational modification levels are tightly regulated in neoplastic cells to maintain cellular processes known as 'cancer hallmarks'. The first Pan-Cancer initiative of The Cancer Genome Atlas (TCGA) Research Network has aggregated protein expression profiles for 3,467 patient samples from 11 tumor types using the antibody based reverse phase protein array (RPPA) technology. The resultant proteomic data can be utilized to computationally infer protein-protein interaction (PPI) networks and to study the commonalities and differences across tumor types. In this study, we compare the performance of 13 established network inference methods in their capacity to retrieve the curated Pathway Commons interactions from RPPA data. We observe that no single method has the best performance in all tumor types, but a group of six methods, including diverse techniques such as correlation, mutual information, and regression, consistently rank highly among the tested methods. We utilize the high performing methods to obtain a consensus network; and identify four robust and densely connected modules that reveal biological processes as well as suggest antibody-related technical biases. Mapping the consensus network interactions to Reactome gene lists confirms the pan-cancer importance of signal transduction pathways, innate and adaptive immune signaling, cell cycle, metabolism, and DNA repair; and also suggests several biological processes that may be specific to a subset of tumor types. Our results illustrate the utility of the RPPA platform as a tool to study proteomic networks in cancer.

Download full-text PDF

http://dx.doi.org/10.1371/journal.pcbi.1004765DOI Listing
February 2016

Publication Analysis

Top Keywords

tumor types
biological processes
protein expression
network inference
consensus network
diverse techniques
techniques correlation
correlation mutual
including diverse
methods including
types group
group methods
performance tumor
best performance
regression consistently
utilize high
high performing
performing methods
methods consensus

Similar Publications

TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.

Mol Cell Proteomics 2019 08 14;18(8 suppl 1):S15-S25. Epub 2019 Jun 14.

‡Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Reverse-phase protein arrays represent a powerful functional proteomics approach to characterizing cell signaling pathways and understanding their effects on cancer development. Using this platform, we have characterized ∼8,000 patient samples of 32 cancer types through The Cancer Genome Atlas and built a widely used, open-access bioinformatic resource, The Cancer Proteome Atlas (TCPA). To maximize the utility of TCPA, we have developed a new module called "TCGA Pan-Cancer Analysis," which provides comprehensive protein-centric analyses that integrate protein expression data and other TCGA data across cancer types. Read More

View Article and Full-Text PDF
August 2019

INBIA: a boosting methodology for proteomic network inference.

BMC Bioinformatics 2018 07 9;19(Suppl 7):188. Epub 2018 Jul 9.

Department of Computer Science, University of Verona, Strada le Grazie 15, Verona, 37134, Italy.

Background: The analysis of tissue-specific protein interaction networks and their functional enrichment in pathological and normal tissues provides insights on the etiology of diseases. The Pan-cancer proteomic project, in The Cancer Genome Atlas, collects protein expressions in human cancers and it is a reference resource for the functional study of cancers. However, established protocols to infer interaction networks from protein expressions are still missing. Read More

View Article and Full-Text PDF
July 2018

Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.

BMC Med Genomics 2019 07 11;12(Suppl 5):94. Epub 2019 Jul 11.

Department of Computer Engineering, Ajou University, Suwon, 16499, South Korea.

Background: The analysis of integrated multi-omics data enables the identification of disease-related biomarkers that cannot be identified from a single omics profile. Although protein-level data reflects the cellular status of cancer tissue more directly than gene-level data, past studies have mainly focused on multi-omics integration using gene-level data as opposed to protein-level data. However, the use of protein-level data (such as mass spectrometry) in multi-omics integration has some limitations. Read More

View Article and Full-Text PDF
July 2019

A pan-cancer proteomic perspective on The Cancer Genome Atlas.

Nat Commun 2014 May 29;5:3887. Epub 2014 May 29.

Department of Systems Biology, 1515 Holcombe Blvd, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

Protein levels and function are poorly predicted by genomic and transcriptomic analysis of patient tumours. Therefore, direct study of the functional proteome has the potential to provide a wealth of information that complements and extends genomic, epigenomic and transcriptomic analysis in The Cancer Genome Atlas (TCGA) projects. Here we use reverse-phase protein arrays to analyse 3,467 patient samples from 11 TCGA 'Pan-Cancer' diseases, using 181 high-quality antibodies that target 128 total proteins and 53 post-translationally modified proteins. Read More

View Article and Full-Text PDF
May 2014